Teladoc, Inc. (TDOC): Jason N Gorevic , President & CEO of Teladoc, Inc. sold 5,000 shares on Jul 15, 2016. The Insider selling transaction was reported by the company on Jul 15, 2016 to the Securities and Exchange Commission. The shares were sold at $15.45 per share for a total value of $77,250.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jul 1, 2016, James K Outland (director) sold 10,000 shares at $15.00 per share price.On Jul 1, 2016, Jason N Gorevic (President & CEO) sold 5,000 shares at $15.01 per share price.Also, On Mar 18, 2016, Dana G Jr. Mead (director) purchased 10,000 shares at $10.65 per share price.On Mar 18, 2016, Martin R Felsenthal (director) purchased 9,900 shares at $10.61 per share price.
Shares of Teladoc Inc (TDOC) ended Friday, Jul 15, 2016 session in red amid volatile trading. The shares closed down -0.06 points or -0.39% at $15.45 with 6,18,874 shares getting traded. Post opening the session at $15.51, the shares hit an intraday low of $15.24 and an intraday high of $15.84 and the price vacillated in this range throughout the day. The company has a market cap of $598 M and the number of outstanding shares has been calculated to be 3,87,11,092 shares. The 52-week high of Teladoc Inc is $35.42 and the 52-week low is $9.08.
Company has been under the radar of several Street Analysts.Teladoc Inc is Reiterated by Piper Jaffray to Overweight and the brokerage firm has raised the Price Target to $ 22 from a previous price target of $20 .The Rating was issued on Jul 11, 2016.Teladoc Inc is Initiated by Piper Jaffray to Overweight. The Rating was issued on May 26, 2016.
Teladoc Inc. is a telehealth company. The Company offers an on-demand healthcare platform through mobile devices Internet video and phone. Its solution connects consumers with physicians and behavioral health professionals or its providers who treat various conditions and cases from acute diagnoses such as upper respiratory infection urinary tract infection and sinusitis to dermatological conditions anxiety and smoking cessation. The Teladoc solution enables accessing on-demand healthcare for employers health plans and health systems. Its platform provides accessing physicians clinical programs and consumer engagement strategies. Its platform provides for interconnectivity between healthcare constituents. It offers solutions such as remote patient monitoring post-discharge treatment plan adherence and in-home and chronic care. Its customers also include channel partners such as brokers resellers and consultants who sell into a range of small medium and large enterprises.